RE: IOV effects
From: "Piotrovskij, Vladimir [JanBe]" <VPIOTROV@janbe.jnj.com>
Subject: RE: IOV effects
Date: Tue, 23 Nov 1999 15:52:36 +0100
It is the question of study design. If you are going to estimate IOV separately and independently from IIV you should design your study accordingly. In case you have only a small proportion of subjects tested at different occasions mixed-effects modelling will not help you irrespective to the program you use (NONMEM, nlme, a new SAS PROC (I forgot the name), etc.).
Vladimir
----------------------------------------------------------------------
Vladimir Piotrovsky, Ph.D.
Janssen Research Foundation
Clinical Pharmacokinetics
B-2340 Beerse
Belgium
Email: vpiotrov@janbe.jnj.com